On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...

For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

People with low back pain might want to look into the ancient Chinese mind-body movement exercise known as qigong, a ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...